Edit
CORE Biomedicine, Inc. --> CORE Biomedicine, Inc.
https://corebiomedicine.com/Last activity: 31.07.2026
Probably Closed
Reimagining Precision Medicine Through Cancer Lineage Therapeutics. We develop therapies that go beyond genomic alterations to target the core lineage pathways tumors depend on.
Total raised: $21M
Investors 1
| Date | Name | Website |
| 01.09.2025 | Vision Inc... | visionincu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.07.2026 | Series A | $21M | - |
Mentions in press and media 3
| Date | Title | Description |
| 31.07.2026 | CORE Biomedicine Raises $21 Million Series A And Receives AMED Grant For Cancer Programs | CORE Biomedicine has raised $21 million in Series A financing and received a grant from the Japan Agency for Medical Research and Development to advance precision oncology programs based on cancer cell lineage. The venture round was co-led ... |
| 28.07.2026 | CORE Biomedicine Scores $21M Series A | BOSTON, MA, CORE Biomedicine, a biotechnology company pioneering lineage-based precision oncology therapeutics, today announced the completion of a $21 million Series A financing. >> Click here for more funding data on CORE Biomedici... |
| - | CORE Biomedicine | “Core Biomedicine | Reimagining Precision Medicine Through Cancer Lineage Therapeutics” |